Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Interviewers as Intruders? Ethical Explorations of Joint Family Interviews.

Herzog M, Jürgensen M, Rehmann-Sutter C, Schües C.

J Empir Res Hum Res Ethics. 2019 Jul 25:1556264619857856. doi: 10.1177/1556264619857856. [Epub ahead of print]

PMID:
31342862
2.

"Being a burden to others" and wishes to die: An ethically complicated relation.

Rehmann-Sutter C, Ohnsorge K, Onwuteaka-Philipsen B, Widdershoven G.

Bioethics. 2019 May;33(4):409-410. doi: 10.1111/bioe.12618. No abstract available.

PMID:
31115086
3.

Self-perceived burden to others as a moral emotion in wishes to die. A conceptual analysis.

Rehmann-Sutter C.

Bioethics. 2019 May;33(4):439-447. doi: 10.1111/bioe.12603.

PMID:
31115085
4.

How palliative care patients' feelings of being a burden to others can motivate a wish to die. Moral challenges in clinics and families.

Gudat H, Ohnsorge K, Streeck N, Rehmann-Sutter C.

Bioethics. 2019 May;33(4):421-430. doi: 10.1111/bioe.12590.

5.

Wishes to die at the end of life and subjective experience of four different typical dying trajectories. A qualitative interview study.

Ohnsorge K, Rehmann-Sutter C, Streeck N, Gudat H.

PLoS One. 2019 Jan 17;14(1):e0210784. doi: 10.1371/journal.pone.0210784. eCollection 2019.

6.

Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies.

Sugarman J, Shivakumar S, Rook M, Loring JF, Rehmann-Sutter C, Taupitz J, Reinhard-Rupp J, Hildemann S.

Am J Bioeth. 2018 Aug;18(8):3-6. doi: 10.1080/15265161.2018.1489653. No abstract available.

PMID:
30133390
7.

Why Human Germline Editing is More Problematic than Selecting Between Embryos: Ethically Considering Intergenerational Relationships.

Rehmann-Sutter C.

New Bioeth. 2018 Apr;24(1):9-25. doi: 10.1080/20502877.2018.1441669.

PMID:
29529985
8.

[Ethical aspects of palliative medicine].

Rehmann-Sutter C, Lehnert H.

Internist (Berl). 2016 Oct;57(10):946-952. Review. German.

PMID:
27638186
9.

Saving or Subordinating Life? Popular Views in Israel and Germany of Donor Siblings Created through PGD.

Raz A, Schües C, Wilhelm N, Rehmann-Sutter C.

J Med Humanit. 2017 Jun;38(2):191-207. doi: 10.1007/s10912-016-9388-2.

PMID:
27000646
10.

The new genomic patient.

Rehmann-Sutter C.

Swiss Med Wkly. 2015 Feb 4;145:w14089. doi: 10.4414/smw.2015.14089. eCollection 2015. No abstract available.

11.

What a wish to die can mean: reasons, meanings and functions of wishes to die, reported from 30 qualitative case studies of terminally ill cancer patients in palliative care.

Ohnsorge K, Gudat H, Rehmann-Sutter C.

BMC Palliat Care. 2014 Jul 31;13:38. doi: 10.1186/1472-684X-13-38. eCollection 2014.

12.

Intentions in wishes to die: analysis and a typology--a report of 30 qualitative case studies of terminally ill cancer patients in palliative care.

Ohnsorge K, Gudat H, Rehmann-Sutter C.

Psychooncology. 2014 Sep;23(9):1021-6. doi: 10.1002/pon.3524. Epub 2014 Apr 4.

13.

From global bioethics to ethical governance of biomedical research collaborations.

Wahlberg A, Rehmann-Sutter C, Sleeboom-Faulkner M, Lu G, Döring O, Cong Y, Laska-Formejster A, He J, Chen H, Gottweis H, Rose N.

Soc Sci Med. 2013 Dec;98:293-300. doi: 10.1016/j.socscimed.2013.03.041. Epub 2013 Apr 3.

PMID:
23623168
14.

Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges.

Hens K, Dondorp W, Handyside AH, Harper J, Newson AJ, Pennings G, Rehmann-Sutter C, de Wert G.

Hum Reprod Update. 2013 Jul-Aug;19(4):366-75. doi: 10.1093/humupd/dmt009. Epub 2013 Mar 6. Review.

PMID:
23466750
15.

An alternative view on the task of prognosis.

Bernegger G, Musalek M, Rehmann-Sutter C.

Crit Rev Oncol Hematol. 2012 Dec 31;84 Suppl 2:S17-24. doi: 10.1016/S1040-8428(13)70005-2.

PMID:
23347414
16.

Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational.

McCormack P, Woods S, Aartsma-Rus A, Hagger L, Herczegfalvi A, Heslop E, Irwin J, Kirschner J, Moeschen P, Muntoni F, Ouillade MC, Rahbek J, Rehmann-Sutter C, Rouault F, Sejersen T, Vroom E, Straub V, Bushby K, Ferlini A.

PLoS Curr. 2013 Jan 10;5. pii: ecurrents.md.f90b49429fa814bd26c5b22b13d773ec. doi: 10.1371/currents.md.f90b49429fa814bd26c5b22b13d773ec.

17.

Donating embryos to stem cell research.

Scully JL, Haimes E, Mitzkat A, Porz R, Rehmann-Sutter C.

J Bioeth Inq. 2012 Mar;9(1):19-28. doi: 10.1007/s11673-011-9352-9. Epub 2012 Jan 4.

18.

'Ambivalence' at the end of life: how to understand patients' wishes ethically.

Ohnsorge K, Keller HR, Widdershoven GA, Rehmann-Sutter C.

Nurs Ethics. 2012 Sep;19(5):629-41.

PMID:
22990424
19.

How to relate the empirical to the normative: toward a phenomenologically informed hermeneutic approach to bioethics.

Rehmann-Sutter C, Porz R, Scully JL.

Camb Q Healthc Ethics. 2012 Oct;21(4):436-47. doi: 10.1017/S0963180112000217. No abstract available.

PMID:
22828038
20.

Organised assistance to suicide in England?

Rehmann-Sutter C, Hagger L.

Health Care Anal. 2013 Jun;21(2):85-104. doi: 10.1007/s10728-011-0191-y.

PMID:
21901423
21.

Aging as disease?

Rehmann-Sutter C.

Swiss Med Wkly. 2011 Apr 13;141:w13186. doi: 10.4414/smw.2011.13186. eCollection 2011. No abstract available.

22.

How reproductive and regenerative medicine meet in a Chinese fertility clinic. Interviews with women about the donation of embryos to stem cell research.

Mitzkat A, Haimes E, Rehmann-Sutter C.

J Med Ethics. 2010 Dec;36(12):754-7. doi: 10.1136/jme.2010.036764. Epub 2010 Oct 27.

PMID:
20980331
23.

Sino-European research ethics on the right path.

Rehmann-Sutter C.

Nature. 2010 Jul 1;466(7302):28. doi: 10.1038/466028c. No abstract available.

PMID:
20595992
24.

[Ethical considerations on new developments in reproductive medicine].

Rehmann-Sutter C, Wienroth M.

Ther Umsch. 2009 Dec;66(12):807-11. doi: 10.1024/0040-5930.66.12.807. Review. German.

PMID:
19950059
25.

A challenged choice: donating spare embryos to stem cell research in Switzerland.

Porz R, Bürkli P, Barazzetti G, Leach Scully J, Rehmann-Sutter C.

Swiss Med Wkly. 2008 Sep 20;138(37-38):551-6. doi: 2008/37/smw-12420.

26.

[Moral dignity at the beginning of life. The embryo as a marginal being].

Rehmann-Sutter C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Aug;51(8):835-41. doi: 10.1007/s00103-008-0603-9. Review. German.

PMID:
18787860
27.

"So, what is an embryo?" A comparative study of the views of those asked to donate embryos for hESC research in the UK and Switzerland.

Haimes E, Porz R, Scully J, Rehmann-Sutter C.

New Genet Soc. 2008 Jun;27(2):113-126. Epub 2008 Aug 24.

28.

'You don't make genetic test decisions from one day to the next'--using time to preserve moral space.

Scully JL, Porz R, Rehmann-Sutter C.

Bioethics. 2007 May;21(4):208-17.

PMID:
17845479
29.

[Is informed consent actually possible?].

Rehmann-Sutter C.

Ther Umsch. 2006 Nov;63(11):699-702. Review. German.

PMID:
17075784
30.

Non-professionals' evaluations of gene therapy ethics.

Scully JL, Rippberger C, Rehmann-Sutter C.

Soc Sci Med. 2004 Apr;58(7):1415-25.

PMID:
14759686
31.

Bioethics--an outlook.

Rehmann-Sutter C.

Biomed Ethics. 2000;5(1):16-9. No abstract available.

PMID:
11905467
32.

Why care about the ethics of therapeutic cloning?

Rehmann-Sutter C.

Differentiation. 2002 Jan;69(4-5):179-81. No abstract available.

PMID:
11841474
33.

Liberating gene therapy.

Rehmann-Sutter C.

Hastings Cent Rep. 1999 May-Jun;29(3):43. No abstract available.

PMID:
11645166
34.

When norms normalize: the case of genetic "enhancement".

Scully JL, Rehmann-Sutter C.

Hum Gene Ther. 2001 Jan 1;12(1):87-95.

PMID:
11177546
35.

[Gene therapy and ethics].

Müller H, Rehmann-Sutter C.

Schweiz Med Wochenschr. 1995 Jan 10;125(1-2):34-41. Review. German.

PMID:
7839108
36.

Supplemental Content

Loading ...
Support Center